Ginkgo Bioworks Holdings (NYSE:DNA) shares are trading higher Monday afternoon, up over 8%, following the announcement of a strategic partnership with Carnegie Mellon University under the Advanced Research Projects Agency for Health. Here’s what investors need to know.Ginkgo Bioworks stock is cha... Read more
Benzinga - Dec 22
The King recorded a special message in support of Stand Up to Cancer that was aired on Friday evening Read more
The Independent - Dec 12
OAKLAND, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Alameda Health System (AHS) has been honored with the 2025 Quality Leaders Award (QLA) by the California Association of Public Hospitals and Health Systems (CAPH) and the California Health Care Safety Net Institute (SNI). Read more
Globenewswire_fr - Dec 10
Sir, The decision not to introduce widespread prostate cancer screening is a triumph of statistics over the individual’s health Read more
The Times - Dec 01
IT affects one in eight men, and so it seems logical to have a prostate cancer screening programme. And yet, in a pivotal decision today, deemed "deeply disappointing" by charities, campaign groups and celebrities, top doctors decided against routine testing for a large majority of men. The UK Na... Read more
The Sun - Nov 29
One in four black men will get prostate cancer. For the rest of the population, it's one in eight. These are shocking statistics but, as a black man in my forties, these aren't just numbers to me. Read more
Mail Online - Nov 29
Everything you need to know about the decision on who should be screened for prostate cancer Read more
The Bbc - Nov 28
Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you need to know about who can get checked Read more
Mirror - Nov 28
The UK currently lacks a national, population-wide screening programme for the disease Read more
The Independent - Nov 28
The UK National Screening Committee will meet on Thursday to consider the latest evidence on the costs and benefits before issuing a highly anticipated recommendation. Read more
Mail Online - Nov 25
